EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes

Adnan R Alnaser, Furkan Zurel, Abed Alnsour, Omar N Pathmanaban, Helen Maye, Catherine McMahon, Matthew Bailey, Mueez Waqar

Acta Neurochirurgica · 2026

DOI: 10.1007/s00701-026-06923-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurochirurgica, 2026. Verfasst von Adnan R Alnaser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Ventriculoperitoneal Shunt, Venous Thromboembolism, Postoperative Complications, Hematoma. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Venous thromboembolism (VTE) is a risk in neurosurgery, but data for adults undergoing ventriculoperitoneal (VP) shunt insertion are limited. The safety of post-operative pharmacological thromboprophylaxis in this population remains unclear due to concerns about bleeding. This study evaluated the safety of post-operative pharmacological thromboprophylaxis after VP shunt insertion in adults in relation to VTE and haematoma risk.

Methods

This retrospective cohort study included 246 adult patients who underwent primary VP shunt insertion at a tertiary centre between 2017 and 2021. Data on demographics, aetiology, surgery, radiological imaging, pharmacological thromboprophylaxis, and outcomes (VTE, post-operative haematomas) were collected and reviewed. Univariate analysis and propensity-matching were used to compare outcomes.

Results

Median age was 63 years (range 17–90 years); common hydrocephalus aetiologies were tumour (32.9%) and normal pressure hydrocephalus (30.5%). Pharmacological thromboprophylaxis (median post-operative day 1) was given to 76.0% ( n = 187), alongside universal mechanical prophylaxis. One VTE (pulmonary embolism, 0.4%) event occurred. Routine post-operative imaging detected 12 haematomas (4.9%); 2 (0.8%) were clinically significant: 1 intracerebral haemorrhage requiring surgical evacuation and 1 managed conservatively. Pharmacological thromboprophylaxis did not significantly increase the risk of post-operative haematoma formation overall ( p > 0.99) and in a propensity score matched subgroup analysis that controlled for confounders ( p = 0.36).

Conclusion

In this study, we demonstrate that early pharmacological thromboprophylaxis after primary VP shunt insertion appears to have an acceptable safety profile without significantly increasing haematoma risk. Our findings require validation in future multicentre cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventriculoperitoneal ShuntVenous ThromboembolismPostoperative ComplicationsHematomaAnticoagulantsPostoperative HemorrhageHumansFemaleMiddle AgedMaleAged, 80 and overAgedAdultRetrospective StudiesAdolescentYoung AdultHydrocephalus

Stichwörter der Autor:innen

ChemoprophylaxisHaematomaHeparinPharmacological thromboprophylaxisProphylaxisVP ShuntVTEVenous thromboembolismVentriculoperitoneal shunt

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Neurosurgery, Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford, Manchester, United Kingdom.
  • Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, United Kingdom.
  • Department of Neurosurgery, Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford, Manchester, United Kingdom. mueez.waqar@nhs.net.
  • Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, United Kingdom. mueez.waqar@nhs.net.

Zitieren

APA

Alnaser, A. R., Zurel, F., Alnsour, A., Pathmanaban, O. N., Maye, H., McMahon, C., Bailey, M., & Waqar, M. (2026). Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes. Acta Neurochirurgica. https://doi.org/10.1007/s00701-026-06923-2

Vancouver

Alnaser AR, Zurel F, Alnsour A, Pathmanaban ON, Maye H, McMahon C, et al. Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes. Acta Neurochirurgica. 2026. doi:10.1007/s00701-026-06923-2

BibTeX
@article{Alnaser2026,
  author = {Alnaser, Adnan R and Zurel, Furkan and Alnsour, Abed and Pathmanaban, Omar N and Maye, Helen and McMahon, Catherine and Bailey, Matthew and Waqar, Mueez},
  title = {Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes},
  journal = {Acta Neurochirurgica},
  year = {2026},
  doi = {10.1007/s00701-026-06923-2}
}
Kostenlos starten →